We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Two Drifters Distillery (TDD) is one of the very few British distilleries that makes rum from raw ingredients, rather than importing and flavouring it. It has worked with Climeworks Direct Air Capture technology to remove CO2 from its products. The company's technique won admirers leading to a boost in sales. Since its launch in 2019, TDD converted existing equipment to increase capacity from 80 bottles per week to an estimated 1800 per week. It has also secured contracts from prominent entities including John Lewis (national and online), Exeter Chiefs Rum and Virgin Wines. The company has an active social media community with 10,000+ followers and also conducts weekly distillery tours that see full attendance from its customers. TDD has also received press coverage from media houses including The BBC, The Telegraph and The Independent. It will use the investment to grow its sales and showcase its product at retail outlets, and bring to the masses sustainably-made British products.

Pitch Rated

40%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £286,340
NY Slice has become a Glasgow phenomenon in only 1 year. Acclaimed by critics, bloggers and national media, it is taking the local market by storm. Our authentic New York offering of pizza by the slice & whole pizzas up to 18"s for dine in, takeout or delivery is revolutionising pizza in the City. We have invested significantly in creating and perfecting a model that is easily scalable across the UK & beyond. With the appropriate funding we can grow to from 7 stores in year 1 to 80 in year 5
days to go: Expired investment: Withheld
DNApal is a personalised diet, health and fitness app that combines DNA infomation with other factors like age, weight, diet, family history and health goals. Two of the largest consumer DNA companies, 23andMe and Ancestry.com, have tested over 18m people. DNApal is capable of interpreting DNA results from these companies to provide precise recommendations on how to improve diet, hormone balance, weight loss, sleep, fitness & more. The company also won the best pitch at VentureFest 2019 at Oxford Brookes University. DNApal is aiming to launch MVP in January 2020 (iOS). The company is also aiming to recommend further testing and specific supplements where necessary and offer 1:1 consultations with a specialist. With the fund raised, DNApal plans to develop the full scope of the app, weekly goals, content challenges to keep users committed.

Pitch Rated

70%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £49,990
Bringing an Italian tradition to the UK, the team at Miccone are raising funds to open their first permanent site in London. 22% of British Adults choose Italian food when eating out, so the team are bringing their experience from an Italian Miccone in Pavia to the streets of London.
days to go: Expired investment: £85,920
The company operates within the Fast Moving Consumer Goods market and will be launching KOKONATA drink product.KOKONATA coconut water is a particular variety of coconut that is indigenous to the tropical island of Sri Lanka called “King Coconut” this is a particular type of Yellow Coconut which is only grown in this region.  On the Island, Kokonata coconut trees grow freely and in abundance with little or no human intervention. Its taste and ability to replenish the body make it the premium source of hydration, hence the name “King” of all coconuts.You need to be registered as an investor to see thisJoin Now
days to go: Expired investment: Withheld
Winebuyers connect vineyards and wine merchants directly to the end consumer revolutionising a traditional industry.  They make their revenue by charging the suppliers a monthly fee and have had 2,700 companies registering their interest to be involved in the platform.  The funding will go towards strengthening their infrastructure, extending their marketing activities and to growing the business quickly and efficiently. (SEIS Partial)
days to go: Expired investment: £568,870
Cranes develop acoholic, cranberry flavoured drinks. Currently their product range consists of 3 different variations of cranberry cider and also a cranberry liqueur. Current stockists include the online supermarket Ocado, as well as many other local shops and bars.
days to go: Expired investment: £194,634
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph